# Wells Pharma of Houston LLC – FDA Inspection, Apr 13, 2026

Source: https://www.keypedia.com/records/fda_inspections/wells-pharma-of-houston-llc/1b69b978-6820-44d2-93c7-77c431525aa3
Source feed: FDA_Inspections

> FDA inspection 1302362 of Wells Pharma of Houston LLC, April 13, 2026. 6 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1302362
- Company Name: Wells Pharma of Houston LLC
- Inspection Date: 2026-04-13
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Dallas District Office
- Citation Count: 6

## Related Documents

- [FDA Inspection 1266232 - 2025-03-28](https://www.keypedia.com/records/fda_inspections/wells-pharma-of-houston-llc/e551c869-05e4-4af7-8e72-26e70172f5b4)
- [FDA Inspection 1193883 - 2022-12-14](https://www.keypedia.com/records/fda_inspections/wells-pharma-of-houston-llc/c8cff647-1ce7-4e40-92d9-1a3d32332820)
- [FDA Inspection 1144681 - 2021-06-17](https://www.keypedia.com/records/fda_inspections/wells-pharma-of-houston-llc/08c48720-4f39-4c03-97bb-5fc4b9adc1ed)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/camerson-e-moore/50733244-0d55-4b0b-a758-f192b7c66457)

Company: https://www.keypedia.com/companies/wells-pharma-of-houston-llc/35e803e2-78a7-4b40-b467-4c1ff012447d

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9